Search Results 1181-1190 of 17641 for treatment resistant depression

  1. Clinical trials - Oncology (Medical)

    ... treatment of patients with chronic myelomonocytic leukemia that has come back (recurrent) or that does not respond to treatment (refractory). Onvansertib is a ...

  2. Atopic dermatitis (eczema) - Diagnosis and treatment - Mayo Clinic

    Do you or any family members have allergies or asthma? Are you exposed to any possible irritants from your job or hobbies? Have you felt depressed or been under ...

  3. Clinical trials - Oncology (Medical)

    ... treating patients with B-cell non-Hodgkin lymphoma that has returned (recurrent) or did not respond to treatment (refractory). Monoclonal antibodies, such ...

  4. A Phase 1 Dose Escalation and Expansion Study of TGR-1202 + Ruxolitinib in Subjects with Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (PPV-MF), Post-Essential Thrombocythemia MF (PET-MF), MDS/MPN, or Polycythemia Vera Resistant to Hydroxyurea - Mayo Clinic

    By condition, treatment or drug name. Search tips ... Resistant to Hydroxyurea. Print details. Share ... treatment has been approved and is on the market.

  5. A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HPN217 in Patients with Relaped/Refractory Multiple Myeloma - Mayo Clinic

    The purpose of this study is to evaluate HPN217 as monotherapy to assess the safety, tolerability and pharmacokinetics in patients with relapsed/ refractory ...

  6. Using Technology to Optimize Child Mental Health Care In Real World Settings - Mayo Clinic

    By condition, treatment or drug name ... treatment tools to treat those with a mental health illness. ... depression, disruptive behavior); English speaking ...

  7. A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

    A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic ...

  8. CAR-T Cell Therapy Program - Clinical trials

    Rochester, Minn. The purpose of this study is to determine the safety and best dose of PRGN-3006 T Cells to treat relapsed/refractory Acute Myeloid Leukemia and ...

  9. Publications - Loren P. Murray, M.D. - Mayo Clinic

    Treatment Approach of Refractory ... Telephone-based, cognitive-behavioral therapy for African American dementia caregivers with depression: initial findings.

  10. Phase 2 Study of Ruxolitinib Versus Anagrelide in Subjects With Essential Thrombocythemia Who Are Resistant to or Intolerant of Hydroxyurea (RESET-272) - Mayo Clinic

    By condition, treatment or drug name. Search tips ... Phase 2 Study of Ruxolitinib Versus Anagrelide in Subjects With Essential Thrombocythemia Who Are Resistant ...